Peer-reviewed research demonstrating measurable improvements in stress, depression, anxiety, and biological health markers across diverse populations.
Rigorous Scientific Methodology
RCT Design
Randomized controlled trials with proper control groups and blinding protocols
Validated Scales
HAM-A, HAM-D, PSS-10, and other clinically validated assessment instruments
Biomarkers
Objective biological measurements including blood work and physiological indicators
Diverse Cohorts
Studies across student, clinical, and general populations with varied demographics
Yale University
Reduces Stress and Depression in College Students
Randomized controlled trial comparing SKY breathing techniques with Emotional Intelligence training and Mindfulness-Based Stress Reduction among university students over 8 weeks (30 contact hours).
RCT
8 Weeks
N = 30
University Population
Primary Outcome
−0.32 β
Stress Reduction (PSS-10)
Standardized beta coefficient indicating significant decrease in perceived stress levels
− 0.29
Depression
+ 0.30
Positive Affect
+ 0.26
Mindfulness
+ 0.21
Social Connection
Effect Sizes Comparison
Stress Reduction
β = −0.32
Depression
β = −0.29
Positive Affect
β = +0.30
Mindfulness
β = +0.26
Social Connection
β = +0.21
Social Connection
Control (n=47)
SKY (n=29)
EI (n=21)
MBSR (n=34)
What This Means
After 8 weeks of SKY practice, college students showed measurable reductions in stress and depression symptoms, alongside improvements in emotional well-being, mindfulness awareness, and social connectedness. These effects were statistically significant compared to control groups, demonstrating SKY’s efficacy in supporting mental health during academically demanding periods.
National Institute of Mental Health and Neuro Sciences, Bangalore
Clinically Significant Remission in Severe Depression
Controlled clinical study comparing SKY with electroconvulsive therapy (ECT) and imipramine medication in hospitalized patients diagnosed with melancholic depression over 4 weeks of treatment.
Clinical Trial
4 Weeks
N = 45
Hospitalized Patients
SKY Primary Outcome
67 %
Remission Rate
10 of 15 patients achieved full remission criteria within 4 weeks
Treatment Comparison
Sudarshan Kriya Yoga (SKY)
n = 15
67%
10/15
Imipramine (Medication)
n = 15
73%
11/15
Electroconvulsive Therapy (ECT)
n = 15
93%
14/15
45
Total Enrolled
3
Equal Groups
4
Weeks Duration
What This Means
In severe, hospitalized melancholic depression, SKY breathing practice demonstrated substantial remission rates within just 4 weeks—comparable to pharmaceutical intervention and approaching ECT outcomes. This suggests SKY can be a valuable treatment option even for clinically severe depression, offering a non-pharmacological pathway to recovery with significant clinical efficacy.
National Institute of Mental Health and Neuro Sciences, Bangalore
Improvement Without Medication
Study examining SKY as a standalone intervention for depression without pharmaceutical support, with assessments at baseline, 1 month, and 3 months to evaluate sustained benefits.
Longitudinal Study
3 Month Follow-up
N = 30
Drug-Free Protocol
Response Rate
73%
Response Rate
22
Responded
8
Non-Responders
Participant Outcomes
Total Participants
30
Positive Response
22
Response Rate
73%
Medication Used
0
What This Means
Nearly 3 in 4 participants improved by practicing SKY alone, without medication. This demonstrates that breathing-based interventions can serve as effective standalone treatments for depression, offering a non-pharmaceutical pathway that may be particularly valuable for individuals seeking drug-free approaches or those who cannot tolerate psychiatric medications.
START Clinic for Mood and Anxiety Disorders, Toronto
An open-label pilot study examined SKY as an addition to existing treatment for adults with generalized anxiety disorder who had not achieved remission after at least eight weeks of conventional care. Outcomes were measured using the Hamilton Anxiety Rating Scale, or HAM-A.
Clinical Pilot Study
Adjunctive Treatment
4-Week Follow-up
N = 41 Enrolled
PRIMARY RESPONSE
Response Rate
At least a 50% reduction in HAM-A scores
21 of 29 participants included in the outcome analysis
Achieved Remission
HAM-A score of 7 or lower
12 of 29 participants included in the outcome analysis
STATISTICAL RESULT
t-value
Significant pre-to-post reduction in anxiety scores
PARTICIPANT FLOW
41
Enrolled
Treatment-resistant GAD
31
Completed
76% completion rate
29
Outcome Analysis
Included in analysis
21
Responded
≥50% HAM-A reduction
12
Reached Remission
HAM-A ≤7
73%
Response Rate
41%
Remission Rate
4.59
t-value
P < 0.01
Significance
What This Means
In this small open-label pilot, SKY was used alongside standard treatment rather than replacing it. Participants showed significant improvement in anxiety, including a 73% response rate and a 41% remission rate. The findings are promising for people who had not previously reached remission, while larger controlled studies are still needed.
SRM Medical College, Hospital and Research Centre, TN, India
Measurable Biological Changes
A randomized controlled trial measured lipid and blood-cell markers in university students at baseline, during an examination period, and after three and six weeks of SKY and pranayama practice.
RCT
6 Week Study
N = 40 Analyzed
Biomarker Assessment
Primary Outcome
Triglycerides
Decreased
Statistical Significance
P < 0.001
Time Point
6 Weeks
Total Cholesterol
P < 0.05
VLDL Cholesterol
P < 0.01
Lymphocytes
P < 0.01
STUDY TIMELINE & MEASUREMENTS
Baseline
Initial blood work and stress assessment
Triglycerides · Cholesterol · VLDL · Lymphocytes
Exam Period
During high-stress examination period
↑ Cholesterol increased (P < 0.01)
↑ Triglycerides increased (P < 0.001)
3 Weeks Post-Intervention
Mid-point assessment
Markers trending toward improvement
6 Weeks Post-Intervention
Final assessment showing significant changes
All primary markers improved
Effects sustained over time
BIOMARKER CHANGES OVER TIME
Biomarker
Baseline
Exam Period
3 Weeks
6 Weeks
Significance
Triglycerides
Normal
↑ Elevated
↓ Decreasing
↓ Reduced
P < 0.001
Total Cholesterol
Normal
↑ Elevated
↓ Decreasing
↓ Reduced
P < 0.05
VLDL
Normal
Stable
↓ Decreasing
↓ Reduced
P < 0.01
Lymphocytes
Normal
Stable
↑ Increasing
↑ Elevated
P < 0.01
43
Enrolled
40
Analyzed
19
Control Group
21
SKY Group
What This Means
SKY influenced measurable biological stress markers—not just mood or self-reported symptoms. The practice led to significant improvements in cardiovascular risk factors (triglycerides, cholesterol) and immune function (lymphocytes), demonstrating that breathing techniques can produce objective, physiologically measurable changes in the body’s stress response systems. This provides concrete biological evidence for SKY’s health benefits beyond subjective well-being.
For Students
For Faculty
For Administrators
For Student Leaders
Stay connected
Get inspiring stories, campus updates, program announcements, and simple practices for student well-being.
Meaningful updates, not inbox clutter.
© SKY Campus Happiness 2026